Cas:563-09-7 tris(2,2,3,3,4,4,4-heptafluorobutyl) phosphate manufacturer & supplier

Chemical Name:tris(2,2,3,3,4,4,4-heptafluorobutyl) phosphate

CAS.NO:563-09-7

Synonyms:pc6959

Molecular Formula:C₁₂H₆F₂₁O₄P

Molecular Weight:644.11400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:268.4ºC at 760 mmHg

Density:1.674g/cm3

Index of Refraction:1.304

PSA:54.57000

Exact Mass:643.96700

LogP:7.64300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like pc6959 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pc6959 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pc6959 Use and application,pc6959 technical grade,usp/ep/jp grade.

Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. tris(2,2,3,3,4,4,4-heptafluorobutyl) phosphate manufacturer The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. tris(2,2,3,3,4,4,4-heptafluorobutyl) phosphate supplier The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. tris(2,2,3,3,4,4,4-heptafluorobutyl) phosphate vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. tris(2,2,3,3,4,4,4-heptafluorobutyl) phosphate factory The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population.